Research News

Home » Research News

Video: “Transperineal Prostate Biopsies: a new paradigm in the diagnosis and monitoring of Prostate Cancer”

Awareness Nights, Biopsies, Diagnosis / By / / 1 minute of reading

January 2018 Awareness Night Transperineal Prostate Biopsies: a new paradigm in the diagnosis and monitoring of Prostate Cancer   Dr. Stanley Flax  MB, BCh, FRCSC Staff Urologist, North York General Hospital, Co-Chair, North York General Hospital’s OR Product Standardization & Evaluation Committee, Director, Gale & Graham Wright Prostate Cancer Centre.   Dr. Adam Tunis MD, MSc, FRCPC Clinical Director of Medical Imaging Informatics, Staff Radiologist, North York General Hospital Dept. of Medical Imaging       CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 36:22 minutes 

Video: “Transperineal Prostate Biopsies: a new paradigm in the diagnosis and monitoring of Prostate Cancer” Read More »

Prostate MRI

Imaging / By / / 1 minute of reading

Magnetic resonance imaging (MRI) of the prostate may be used in many clinical scenarios, including primary screening, active surveillance, and in patients with a previous negative biopsy and rising PSA. Scott Eggener, MD, explains whether MRI is warranted in each of these situations and the benefits and challenges this technology presents. Read the article here.

Prostate MRI Read More »

New IsoPSA assay detects prostate cancer more precisely than current tests

PSA Screening, Diagnosis / By / / 1 minute of reading

A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read the article here.

New IsoPSA assay detects prostate cancer more precisely than current tests Read More »

Thousands of men with prostate cancer get risky treatment they don’t need.

Diagnosis / By / / 1 minute of reading

Researchers are developing genetic tests, imaging tests, and algorithms like those in face-recognition software in an effort to reduce the 1 million US men a year who have prostate biopsies and, even more important, reduce the thousands who get treatment they don’t need. Read the article here.

Thousands of men with prostate cancer get risky treatment they don’t need. Read More »

Scroll to Top